News and Reports
-
HBM BioVentures largest public investment - Micrus - acquired by Johnson & Johnson
13 July 2010Download -
Lux Biosciences names Dean Mitchell President and CEO
1 July 2010Download -
HBM Partners to launch new M&A Report at BioBusiness Network conference (29-30 September 2010, Geneva)
30 June 2010Download -
Anthera enrolls first patients in pivotal Varespladib phase 3 clinical study
23 June 2010Download -
PTC Therapeutics awarded $5.4 million grant from the Wellcome Trust
7 June 2010Download -
Nabriva initiates phase II of pleuromutilin antibiotic BC-3781
2 June 2010Download -
Mpex Pharmaceuticals presents positive phase 2 clinical trial results of Aeroquin (MP-376) treatment in Cystic Fibrosis patients
17 May 2010Download -
FDA Advisory Committee to review Lux Biosciences' Uveitis candidate Luveniq
11 May 2010Download -
Asthmatx receives FDA approval for the Alair Bronchial Thermoplasty System
27 April 2010Download -
Interventional Spine announces first US implant of RENEW for lumbar spinal stenosis
19 April 2010Download -
Lux Biosciences Luveniq receives FDA priority review
30 March 2010Download -
Anthera Pharmaceuticals completes Initial Public Offering
4 March 2010Download -
Abbott and Enanta announce advancement of Hepatitis C collaboration
2 March 2010Download -
Lux Biosciences files for Luveniq approval in US and Europe for noninfectious Uveitis
4 February 2010Download -
Kolltan Pharmaceuticals closes $ 10 million series B related financing
20 January 2010Download -
Asthmatx pivotal trial manuscript for Bronchial Thermoplasty published in the American Journal of Respiratory and Critical Care Medicine
12 January 2010Download -
GSK exercises option to progress development of ChemoCentryx's Traficet-EN for the treatment of inflammatory bowel diseases
11 January 2010Download -
ChemoCentryx's Traficet-EN demonstrates effectiveness in Crohn's disease
7 December 2009Download -
Nereus Pharmaceuticals presents positive study of randomized phase 2 clinical trial of Plinabulin (NPI-2358) in non-small cell lung cancer
23 November 2009Download -
Biovitrum - The creation of a new niche specialty pharmaceutical company focused on rare diseases - with strong cash flow generation and growth potential
5 November 2009Download -
Probiodrug closes series B financing round exceeding Euro 36 million (USD 54 million)
2 November 2009Download -
Nabriva Therapeutics raises Euro 15 million (USD 22 million)
28 October 2009Download -
Asthmatx receives FDA advisory panel recommendation for 'approvable with conditions' for bronchial thermoplasty with the Alair system for severe Asthma
28 October 2009Download -
PTC Therapeutics initiates phase 2 clinical trial of Ataluren (PTC124) in patients with Hemophilia
26 October 2009Download -
Lux Biosciences's potential of LUVENIQ (LX211) as first disease modifying treatment for sight-threatening non-infectious Uveitis highlighted at American Academy of Ophthalmology
26 October 2009Download